BioMarin Pharmaceutical Q3 2024 Earnings Preview Oct. 28, 2024 5:35 PM ET By: Nilanjana Basu , SA News Editor [Seeking Alpha]
BioMarin Pharmaceutical Inc. (BMRN)
Last biomarin pharmaceutical inc. earnings: 4/29 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
investors.biomarin.com
Company Research
Source: Seeking Alpha
The consensus EPS Estimate is $0.79 (+71.7% Y/Y) and the consensus Revenue Estimate is $703.27M (+21.0% Y/Y). Over the last 2 years, BMRN has beaten EPS estimates 63% of the time and has beaten revenue estimates 50% of the time. Over the last 3 months, EPS estimates have seen 15 upward revisions and 2 downward. Revenue estimates have seen 15 upward revisions and 3 downward. More on BioMarin Pharmaceutical Ascendis Challenges BioMarin, But Market Response Seems Excessive BioMarin Pharmaceutical: A Volatile But Growing Trajectory BioMarin: Voxzogo Sales Surge Isn't Only Driving Force In 2024 BioMarin resumed at Raymond James at outperform as stock price has hit floor Relief gains as experimental therapy performs on par with BioMarin's Kuvan Recommended For You Comments More Trending News Recommended For You More Trending News
Show less
Read more
Impact Snapshot
Event Time:
BMRN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMRN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMRN alerts
High impacting BioMarin Pharmaceutical Inc. news events
Weekly update
A roundup of the hottest topics
BMRN
News
- CAMP4 Reports Third Quarter 2024 Financial Results [Yahoo! Finance]Yahoo! Finance
- Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Growth Stock [Yahoo! Finance]Yahoo! Finance
- BioMarin Pharmaceutical Inc. (BMRN): Among the Best Genomics Stocks to Buy Right Now [Yahoo! Finance]Yahoo! Finance
- BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024 [Yahoo! Finance]Yahoo! Finance
- BioMarin Presents Real-World Evidence Further Supporting Safety and Efficacy of VOXZOGO® (vosoritide) in Children with Achondroplasia at the European Society for Paediatric Endocrinology (ESPE) Meeting 2024PR Newswire
BMRN
Earnings
- 10/29/24 - Beat
BMRN
Sec Filings
- 11/14/24 - Form 4
- 11/12/24 - Form 144
- 10/31/24 - Form 10-Q
- BMRN's page on the SEC website